Proliferation versus regeneration: the good, the bad and the ugly.
作者信息
Lambrou George I, Remboutsika Eumorphia
机构信息
Choremeio Research Laboratory, First Department of Pediatrics, University of Athens Athens, Greece.
Choremeio Research Laboratory, First Department of Pediatrics, University of Athens Athens, Greece ; Stem Cell Biology Laboratory, Biomedical Sciences Research Centre "Alexander Fleming" Vari-Attica, Greece.
出版信息
Front Physiol. 2014 Jan 28;5:10. doi: 10.3389/fphys.2014.00010. eCollection 2014.
Abstract
摘要
相似文献
1
Proliferation versus regeneration: the good, the bad and the ugly.增殖与再生：善、恶与丑
Front Physiol. 2014 Jan 28;5:10. doi: 10.3389/fphys.2014.00010. eCollection 2014.
2
Glomerular epithelial stem cells: the good, the bad, and the ugly.肾小球上皮干细胞：有好有坏，也有丑陋。
J Am Soc Nephrol. 2010 Oct;21(10):1612-9. doi: 10.1681/ASN.2010010048. Epub 2010 Sep 9.
3
Cell sources for bone regeneration: the good, the bad, and the ugly (but promising).骨再生的细胞来源：有好有坏，也有不太好但有前景的。
Tissue Eng Part B Rev. 2011 Dec;17(6):423-30. doi: 10.1089/ten.teb.2011.0199. Epub 2011 Jul 28.
4
Finding health in folklore, herbs and supplements: the good, the bad & the ugly. Part II-- The ugly.在民俗疗法、草药和补充剂中探寻健康：益处、风险与隐患。第二部分——隐患
Mo Med. 2002 Nov-Dec;99(10):578-9.
5
Classifying microRNAs in cancer: the good, the bad and the ugly.癌症中微小RNA的分类：有益的、有害的和不良的。
Biochim Biophys Acta. 2007 Jun;1775(2):274-82. doi: 10.1016/j.bbcan.2006.11.003. Epub 2006 Nov 22.
6
Three scenarios of clinical claim reimbursement for nosocomial infection: the good, the bad, and the ugly.医院感染临床索赔报销的三种情况：好的、坏的和糟糕的。
J Hosp Infect. 2004 Feb;56(2):150-5. doi: 10.1016/j.jhin.2003.10.014.
7
T-cells in stem cell transplants: dissecting the good, the bad and the ugly.
J Stem Cells Regen Med. 2007 May 16;2(1):26. eCollection 2007.
8
Immunotherapy: the good, the bad, the ugly, and the really ugly.免疫疗法：好的方面、坏的方面、丑陋的方面以及极其丑陋的方面。
Transfusion. 2019 Feb;59(2):437-440. doi: 10.1111/trf.15142.
9
Translating stem cells to the clinic: the good, the bad, and the ugly.将干细胞应用于临床：好的方面、坏的方面与丑陋的方面。
Ann Neurol. 2008 Mar;63(3):A17-21. doi: 10.1002/ana.21253.
10
Pitting the FDA Against CMS: The good, the bad, and the ugly about "parallel review.".使美国食品药品监督管理局与医疗保险和医疗补助服务中心针锋相对：关于“并行审查”的利弊与不堪之处。
Biotechnol Healthc. 2011 Fall;8(3):29-30.
引用本文的文献
1
Should you hold onto the treadmill handrails or not? Cortical evidence at different walking speeds.你是否应该抓住跑步机扶手？不同步行速度下的皮层证据。
J Neuroeng Rehabil. 2025 Jan 16;22(1):5. doi: 10.1186/s12984-025-01543-w.
2
Within or Without You? A Perspective Comparing In Situ and Ex Situ Tissue Engineering Strategies for Articular Cartilage Repair.在体内还是体外？比较原位和异位组织工程策略修复关节软骨的观点。
Adv Healthc Mater. 2022 Dec;11(24):e2201305. doi: 10.1002/adhm.202201305. Epub 2022 Nov 22.
3
Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization.开发一种带有整合素αvβ3配体的可注射纳米纤维细胞外基质水凝胶，以改善内皮细胞存活、植入和血管形成。
Front Bioeng Biotechnol. 2020 Jul 29;8:890. doi: 10.3389/fbioe.2020.00890. eCollection 2020.
4
Insights into regeneration tool box: An animal model approach.再生工具盒的深入研究：一种动物模型方法。
Dev Biol. 2019 Sep 15;453(2):111-129. doi: 10.1016/j.ydbio.2019.04.006. Epub 2019 Apr 13.
5
The use of stem cells in aesthetic dermatology and plastic surgery procedures. A compact review of experimental and clinical applications.干细胞在美容皮肤科和整形手术中的应用。实验与临床应用综述。
Postepy Dermatol Alergol. 2017 Dec;34(6):526-534. doi: 10.5114/ada.2017.72456. Epub 2017 Dec 31.
6
Use of Adipose-Derived Stem Cells to Support Topical Skin Adhesive for Wound Closure: A Preliminary Report from Animal In Vivo Study.使用脂肪干细胞辅助局部皮肤粘合剂进行伤口闭合：一项动物体内研究的初步报告。
Biomed Res Int. 2016;2016:2505601. doi: 10.1155/2016/2505601. Epub 2016 Oct 10.
7
MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.小儿中枢神经系统胚胎性肿瘤中的微小RNA：已知的未知因素
J Hematol Oncol. 2015 Feb 6;8:6. doi: 10.1186/s13045-014-0101-5.
本文引用的文献
1
Niche-dependent gene expression profile of intratumoral heterogeneous ovarian cancer stem cell populations.肿瘤内异质性卵巢癌干细胞群体的生态位依赖性基因表达谱
PLoS One. 2013 Dec 17;8(12):e83651. doi: 10.1371/journal.pone.0083651. eCollection 2013.
2
The role of mesenchymal stem cells in cancer development.间充质干细胞在癌症发展中的作用。
Front Genet. 2013 Nov 27;4:261. doi: 10.3389/fgene.2013.00261.
3
Tumor and its microenvironment: a synergistic interplay.肿瘤及其微环境：协同相互作用。
Semin Cancer Biol. 2013 Dec;23(6 Pt B):522-32. doi: 10.1016/j.semcancer.2013.08.007. Epub 2013 Sep 4.
4
Novel therapeutic strategies for targeting liver cancer stem cells.靶向肝癌干细胞的新型治疗策略。
Int J Biol Sci. 2011 Apr 26;7(5):517-35. doi: 10.7150/ijbs.7.517.
5
Flexibility of neural stem cells.神经干细胞的灵活性。
Front Physiol. 2011 Apr 11;2:16. doi: 10.3389/fphys.2011.00016. eCollection 2011.
6
Origin and maintenance of the intestinal cancer stem cell.肠癌细胞的起源和维持。
Mol Carcinog. 2011 Apr;50(4):254-63. doi: 10.1002/mc.20631.
7
mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.mTORC1 和 mTORC2 通过 RhoA 和 Rac1 信号通路调节结直肠癌的 EMT、迁移和转移。
Cancer Res. 2011 May 1;71(9):3246-56. doi: 10.1158/0008-5472.CAN-10-4058. Epub 2011 Mar 23.
8
Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.胰腺导管腺癌与转录因子：c-Myc的作用
J Gastrointest Cancer. 2011 Jun;42(2):76-84. doi: 10.1007/s12029-011-9258-0.
9
Hippo signaling in oval cells and hepatocarcinogenesis.Hippo 信号通路在卵圆细胞及肝癌发生中的作用。
Cancer Lett. 2011 Mar 28;302(2):91-9. doi: 10.1016/j.canlet.2010.12.008. Epub 2011 Jan 17.
10
Breast cancer stem cells: a new challenge for breast cancer treatment.乳腺癌干细胞：乳腺癌治疗的新挑战。
Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1824-32. doi: 10.2741/3824.
Zotero 插件